REVELATION BIOSCIENCES, INC.

REVB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G/A Feb 17, 2026
DEF 14A Feb 17, 2026 DEF 14A
EFFECT Feb 11, 2026
424B3 Feb 11, 2026 424B3
CORRESP Feb 9, 2026
PRE 14A Feb 6, 2026 PRE 14A
UPLOAD Feb 6, 2026
4 Feb 5, 2026 4
4 Feb 5, 2026 4
4 Feb 5, 2026 4
4 Feb 5, 2026 4
4 Feb 5, 2026 4
S-3 Jan 30, 2026 S-3
8-K Jan 29, 2026 8-K
8-K Jan 22, 2026 8-K
SCHEDULE 13G Jan 20, 2026
4 Jan 12, 2026 4
4 Jan 12, 2026 4
4 Jan 12, 2026 4
4 Jan 12, 2026 4
4 Jan 12, 2026 4
8-K Dec 3, 2025 8-K
SCHEDULE 13G Nov 14, 2025
S-8 Nov 12, 2025 S-8
DEF 14A Nov 10, 2025 DEF 14A
← Newer Page 2 of 16 · 387 filings Older →